CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives
Abstract Acute myeloid leukaemia (AML) remains the most common type of leukaemia in adults. Despite advances in conventional therapies, high relapse rates persist, underscoring the need for novel approaches such as chimeric antigen receptor T (CAR‐T) cell therapy. C‐type lectin‐like molecule‐1 (CLL1...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2025-12-01
|
| Serier: | Clinical and Translational Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/ctm2.70536 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|